Literature DB >> 11867904

Endotoxin inactivation by enterally applied colostrum of different composition.

J Seifert1, M Molkewehrum, S Oesser, L Nebermann, C Schulze.   

Abstract

BACKGROUND AND
PURPOSE: Enteral applied bovine colostrum can significantly reduce endotoxin concentration in plasma. Since colostrum is a mixture of biological active ingredients 3 possible substances which are able to influence the endotoxin elimination were concentrated in 3 different colostrum products. Immunoglobulin-, lactoferrin- and casein-enriched colostra and lactoferrin alone were orally administered to endotoxinaemic rats.
METHODS: Endotoxinaemia was induced to rats by enteral application of 10(10) E. coli together with 40 mg Nebacetin. Control animals received albumin. From all rats plasma samples were taken over the time of 5 h and endotoxin concentration determined with limulus lysate and chromogenic substrate.
RESULTS: Whereas in control animals as well as in animals treated with casein-enriched colostrum a marked increase of endotoxin values to over 130 EU/dl could be observed after 5 h, the oral application of gammaglobulin-enriched and especially lactoferrin-enriched colostrum decreased endotoxin values by more than 50%. The most effective endotoxin elimination was seen with lactoferrin alone.
CONCLUSIONS: From this results it can be concluded that not only gammaglobulin but especially lactoferrin seems to be responsible for the elimination of endotoxin with regard to enterally applied colostrum preparations. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867904     DOI: 10.1159/000048890

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  2 in total

1.  Benefits of bovine colostrum on fecal quality in recently weaned puppies.

Authors:  Catriona J Giffard; Mitsuro M Seino; Peter J Markwell; Roger M Bektash
Journal:  J Nutr       Date:  2004-08       Impact factor: 4.798

2.  KMP01D Demonstrates Beneficial Anti-inflammatory Effects on Immune Cells: An ex vivo Preclinical Study of Patients With Colorectal Cancer.

Authors:  Martin Gasser; Reinhard Lissner; Karol Nawalaniec; Li-Li Hsiao; Ana Maria Waaga-Gasser
Journal:  Front Immunol       Date:  2020-04-30       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.